Guillain-Barré Syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink
Kayla E. Hanson, Kristin Goddard, Ned Lewis, Bruce Fireman, Tanya R. Myers, Nandini Bakshi, Eric Weintraub, James G. Donahue, Jennifer C. Nelson, Stan Xu, Jason M. Glanz, Joshua T.B. Williams, Jonathan D. Alpern, Nicola P. Klein
doi: https://doi.org/10.1101/2021.12.03.21266419
Kayla E. Hanson
1Marshfield Clinic Research Institute, Marshfield, WI
MPHKristin Goddard
2Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA
MPHNed Lewis
2Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA
MPHBruce Fireman
2Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA
MATanya R. Myers
3Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA
PhDNandini Bakshi
4The Permanente Medical Group, Oakland, CA
MDEric Weintraub
3Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA
MPHJames G. Donahue
1Marshfield Clinic Research Institute, Marshfield, WI
DVM, PhDJennifer C. Nelson
5Kaiser Permanente Washington Health Research Institute, Seattle, WA
PhDStan Xu
6Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA
PhDJason M. Glanz
7Kaiser Permanente Colorado Institute for Health Research, Denver, CO
PhDJoshua T.B. Williams
8Ambulatory Care Services, Denver Health & Hospital Authority, Denver, CO
MDJonathan D. Alpern
9HealthPartners Institute, Minneapolis, MN
MDNicola P. Klein
2Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
VSD data are not publicly available but access may be granted through collaboration with VSD sites or the VSD data sharing program. Please visit https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vsd/accessing-data.html for more information.
Posted December 05, 2021.
Guillain-Barré Syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink
Kayla E. Hanson, Kristin Goddard, Ned Lewis, Bruce Fireman, Tanya R. Myers, Nandini Bakshi, Eric Weintraub, James G. Donahue, Jennifer C. Nelson, Stan Xu, Jason M. Glanz, Joshua T.B. Williams, Jonathan D. Alpern, Nicola P. Klein
medRxiv 2021.12.03.21266419; doi: https://doi.org/10.1101/2021.12.03.21266419
Guillain-Barré Syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink
Kayla E. Hanson, Kristin Goddard, Ned Lewis, Bruce Fireman, Tanya R. Myers, Nandini Bakshi, Eric Weintraub, James G. Donahue, Jennifer C. Nelson, Stan Xu, Jason M. Glanz, Joshua T.B. Williams, Jonathan D. Alpern, Nicola P. Klein
medRxiv 2021.12.03.21266419; doi: https://doi.org/10.1101/2021.12.03.21266419
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)